Skip to main content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Journal of Child and Family Studies 4/2014

01-05-2014 | Original Paper

Trends in Psychotropic Medication Use for Medicaid-Enrolled Preschool Children

Auteurs: Cynthia A. Fontanella, Danielle L. Hiance, Gary S. Phillips, Jeffrey A. Bridge, John V. Campo

Gepubliceerd in: Journal of Child and Family Studies | Uitgave 4/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Pharmoepidemiological studies have reported dramatic increases in the use of psychotropic medications for very young children in the 1990s, but more recent trends have not been well-documented. This study describes patterns of psychotropic medication use for Medicaid-enrolled preschool children and identifies factors associated with psychotropic medication use. Using Medicaid claims data, we conducted a trend analysis of psychotropic medication prescribing patterns for the population of preschool children (aged 2–5 years) continuously enrolled in Ohio’s Medicaid program from 2002 to 2008 (N = 559,275). Children were identified as users of psychotropic medications if they had at least one prescription claim during the study period (N = 23,019). The overall rate of psychotropic medication use increased only slightly from 1.7 to 1.9 % between 2002 and 2008. Significant increases in the use of stimulants, alpha-agonist medications, and especially antipsychotics, which more than doubled from .2 % in 2002 to .5 % in 2008, were balanced by significant decreases in the use of antidepressants and mood stabilizers. Of those treated with psychotropic medications, a little over a quarter (28.4 %) had a mental health assessment, 23.7 % had a visit with a psychiatrist, and 29.7 % had a psychotherapy visit. Children who were older, white, male, disabled, and in foster care were more likely to receive psychotropic medications. The diagnoses most associated with psychotropic medication use were ADHD, bipolar disorder, and disruptive behavior disorders. In conclusion, our data suggest growth in the proportion of preschoolers being treated with antipsychotics, stimulants and alpha agonists, primarily for behavioral disturbances and aggressive symptoms. Most preschool children prescribed psychotropic medication do not receive the psychosocial services recommended by current treatment guidelines.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
go back to reference Connor, D. F., Fletcher, K. E., & Swanson, J. M. (1999). A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38(12), 1551–1559. PubMedCrossRef Connor, D. F., Fletcher, K. E., & Swanson, J. M. (1999). A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38(12), 1551–1559. PubMedCrossRef
go back to reference Cooper, W. O., Hickson, G. B., Fuchs, C., Arbogast, P. G., & Ray, W. A. (2004). New users of antipsychotic medications among children enrolled in TennCare. Archives of Pediatrics and Adolescent Medicine, 158(8), 753–759. PubMedCrossRef Cooper, W. O., Hickson, G. B., Fuchs, C., Arbogast, P. G., & Ray, W. A. (2004). New users of antipsychotic medications among children enrolled in TennCare. Archives of Pediatrics and Adolescent Medicine, 158(8), 753–759. PubMedCrossRef
go back to reference Correll, C. U. (2007). Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: A systematic review and pooled analysis of short-term trials. Journal of the American Academy of Child and Adolescent Psychiatry, 46(6), 687–700. PubMedCrossRef Correll, C. U. (2007). Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: A systematic review and pooled analysis of short-term trials. Journal of the American Academy of Child and Adolescent Psychiatry, 46(6), 687–700. PubMedCrossRef
go back to reference Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., & Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA, the Journal of the American Medical Association, 302(16), 1765–1773. CrossRef Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., & Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA, the Journal of the American Medical Association, 302(16), 1765–1773. CrossRef
go back to reference Coyle, J. T. (2000). Psychotropic drug use in very young children. JAMA, the Journal of the American Medical Association, 283(8), 1059–1060. CrossRef Coyle, J. T. (2000). Psychotropic drug use in very young children. JAMA, the Journal of the American Medical Association, 283(8), 1059–1060. CrossRef
go back to reference Crystal, S., Akincigil, A., Bilder, S., & Walkup, J. T. (2007). Studying prescription drug use and outcomes with Medicaid claims data. Medical Care, 45(10 sup 2), S58–S65. Crystal, S., Akincigil, A., Bilder, S., & Walkup, J. T. (2007). Studying prescription drug use and outcomes with Medicaid claims data. Medical Care, 45(10 sup 2), S58–S65.
go back to reference Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009). Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Affairs (Project Hope), 28(5), w770–w781. CrossRef Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009). Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Affairs (Project Hope), 28(5), w770–w781. CrossRef
go back to reference Davis, D., & Williams, P. (2011). Attention deficit/hyperactivity disorder in preschool-age children: Issues and concerns. Clinical Pediatrics, 50(2), 144–152. PubMedCrossRef Davis, D., & Williams, P. (2011). Attention deficit/hyperactivity disorder in preschool-age children: Issues and concerns. Clinical Pediatrics, 50(2), 144–152. PubMedCrossRef
go back to reference DeBar, L. L., Lynch, F., Powell, J., & Gale, J. (2003). Use of psychotropic agents in preschool children: Associated symptoms, diagnoses, and health care services in a health maintenance organization. Archives of Pediatrics and Adolescent Medicine, 157(2), 150–157. PubMedCrossRef DeBar, L. L., Lynch, F., Powell, J., & Gale, J. (2003). Use of psychotropic agents in preschool children: Associated symptoms, diagnoses, and health care services in a health maintenance organization. Archives of Pediatrics and Adolescent Medicine, 157(2), 150–157. PubMedCrossRef
go back to reference dosReis, S., Zito, J. M., Safer, D. J., & Soeken, K. L. (2001). Mental health services for youths in foster care and disabled youths. American Journal of Public Health, 91(7), 1094–1099. PubMedCentralPubMedCrossRef dosReis, S., Zito, J. M., Safer, D. J., & Soeken, K. L. (2001). Mental health services for youths in foster care and disabled youths. American Journal of Public Health, 91(7), 1094–1099. PubMedCentralPubMedCrossRef
go back to reference Fanton, J., & Gleason, M. M. (2009). Psychopharmacology and preschoolers: A critical review of current conditions. Child and Adolescent Psychiatric Clinics of North America, 18(3), 753–771. PubMedCrossRef Fanton, J., & Gleason, M. M. (2009). Psychopharmacology and preschoolers: A critical review of current conditions. Child and Adolescent Psychiatric Clinics of North America, 18(3), 753–771. PubMedCrossRef
go back to reference Gleason, M. M., Egger, H. L., Emslie, G. J., Greenhill, L. L., Kowatch, R. A., Lieberman, A. F., et al. (2007). Psychopharmacological treatment for very young children: Contexts and guidelines. Journal of the American Academy of Child and Adolescent Psychiatry, 46(12), 1532–1572. PubMedCrossRef Gleason, M. M., Egger, H. L., Emslie, G. J., Greenhill, L. L., Kowatch, R. A., Lieberman, A. F., et al. (2007). Psychopharmacological treatment for very young children: Contexts and guidelines. Journal of the American Academy of Child and Adolescent Psychiatry, 46(12), 1532–1572. PubMedCrossRef
go back to reference Gracious, B. L., & Findling, R. L. (2001). Antipsychotic medications for children and adolescents. Pediatric Annals, 30(3), 138–145. PubMed Gracious, B. L., & Findling, R. L. (2001). Antipsychotic medications for children and adolescents. Pediatric Annals, 30(3), 138–145. PubMed
go back to reference Harrison, J. N., Cluxton-Keller, F., & Gross, D. (2012). Antipsychotic medication prescribing trends in children and adolescents. Journal of Pediatric Health Care, 26(2), 139–145. PubMedCentralPubMedCrossRef Harrison, J. N., Cluxton-Keller, F., & Gross, D. (2012). Antipsychotic medication prescribing trends in children and adolescents. Journal of Pediatric Health Care, 26(2), 139–145. PubMedCentralPubMedCrossRef
go back to reference Jerrell, J. M., & McIntyre, R. S. (2008). Adverse events in children and adolescents treated with antipsychotic medications. Human Psychopharmacology, 23(4), 283–290. PubMedCrossRef Jerrell, J. M., & McIntyre, R. S. (2008). Adverse events in children and adolescents treated with antipsychotic medications. Human Psychopharmacology, 23(4), 283–290. PubMedCrossRef
go back to reference Kerker, B. D., & Dore, M. M. (2006). Mental health needs and treatment of foster youth: Barriers and opportunities. American Journal of Orthopsychiatry, 76(1), 138–147. PubMedCrossRef Kerker, B. D., & Dore, M. M. (2006). Mental health needs and treatment of foster youth: Barriers and opportunities. American Journal of Orthopsychiatry, 76(1), 138–147. PubMedCrossRef
go back to reference Kratochvil, C. J., Vaughan, B. S., Mayfield-Jorgensen, M. L., March, J. S., Kollins, S. H., Murray, D. W., et al. (2007). A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17(2), 175–185. PubMedCrossRef Kratochvil, C. J., Vaughan, B. S., Mayfield-Jorgensen, M. L., March, J. S., Kollins, S. H., Murray, D. W., et al. (2007). A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17(2), 175–185. PubMedCrossRef
go back to reference Lieberman, J. A. (2003). The use of antipsychotics in primary care. Primary Care Companion Journal of Clinical Psychiatry, 5(Suppl 3), 3–8. Lieberman, J. A. (2003). The use of antipsychotics in primary care. Primary Care Companion Journal of Clinical Psychiatry, 5(Suppl 3), 3–8.
go back to reference Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121(3), e441–e448. PubMedCentralPubMedCrossRef Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121(3), e441–e448. PubMedCentralPubMedCrossRef
go back to reference Morrato, E., Druss, B., Hartung, D., Valuck, R., Allen, R., Campagna, E., et al. (2010). Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Archives of General Psychiatry, 67(1), 17–24. PubMedCrossRef Morrato, E., Druss, B., Hartung, D., Valuck, R., Allen, R., Campagna, E., et al. (2010). Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Archives of General Psychiatry, 67(1), 17–24. PubMedCrossRef
go back to reference Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41(5), 514–521. PubMedCrossRef Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41(5), 514–521. PubMedCrossRef
go back to reference Pappagallo, M., & Silva, R. (2004). The effect of atypical antipsychotic agents on prolactin levels in children and adolescents. Journal of Child And Adolescent Psychopharmacology, 14(3), 359–371. PubMedCrossRef Pappagallo, M., & Silva, R. (2004). The effect of atypical antipsychotic agents on prolactin levels in children and adolescents. Journal of Child And Adolescent Psychopharmacology, 14(3), 359–371. PubMedCrossRef
go back to reference Patel, N. C., Crismon, M. L., Hoagwood, K., Johnsrud, M. T., Rascati, K. L., Wilson, J. P., et al. (2005). Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 44(6), 548–556. PubMedCrossRef Patel, N. C., Crismon, M. L., Hoagwood, K., Johnsrud, M. T., Rascati, K. L., Wilson, J. P., et al. (2005). Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 44(6), 548–556. PubMedCrossRef
go back to reference Patel, N. C., Sanchez, R. J., Johnsrud, M. T., & Crismon, M. L. (2002). Trends in antipsychotic use in a Texas medicaid population of children and adolescents: 1996 to 2000. Journal of Child and Adolescent Psychopharmacology, 12(3), 221–229. doi: 10.​1089/​1044546027603869​05. PubMedCrossRef Patel, N. C., Sanchez, R. J., Johnsrud, M. T., & Crismon, M. L. (2002). Trends in antipsychotic use in a Texas medicaid population of children and adolescents: 1996 to 2000. Journal of Child and Adolescent Psychopharmacology, 12(3), 221–229. doi: 10.​1089/​1044546027603869​05. PubMedCrossRef
go back to reference Pathak, P., West, D., Martin, B., Helm, M., & Henderson, C. (2010). Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population. Psychiatric Services, 61(2), 123–129. PubMedCrossRef Pathak, P., West, D., Martin, B., Helm, M., & Henderson, C. (2010). Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population. Psychiatric Services, 61(2), 123–129. PubMedCrossRef
go back to reference Rappley, M. D. (2006). Actual psychotropic medication use in preschool children. Infants & Young Children, 19(2), 154–163. CrossRef Rappley, M. D. (2006). Actual psychotropic medication use in preschool children. Infants & Young Children, 19(2), 154–163. CrossRef
go back to reference Rappley, M. D., Eneli, I. U., Mullan, P. B., Alvarez, F. J., Wang, J., Luo, Z., et al. (2002). Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics, 23(1), 23–30. PubMedCrossRef Rappley, M. D., Eneli, I. U., Mullan, P. B., Alvarez, F. J., Wang, J., Luo, Z., et al. (2002). Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics, 23(1), 23–30. PubMedCrossRef
go back to reference Rappley, M. D., Mullan, P. B., Alvarez, F. J., Eneli, I. U., Wang, J., & Gardiner, J. C. (1999). Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. Archives of Pediatrics and Adolescent Medicine, 153(10), 1039–1045. PubMedCrossRef Rappley, M. D., Mullan, P. B., Alvarez, F. J., Eneli, I. U., Wang, J., & Gardiner, J. C. (1999). Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. Archives of Pediatrics and Adolescent Medicine, 153(10), 1039–1045. PubMedCrossRef
go back to reference Silber, J. H., Gleeson, S. P., & Zhao, H. (1999). The influence of chronic disease on resource utilization in common acute pediatric conditions. Financial concerns for children’s hospitals. Archives of Pediatrics and Adolescent Medicine, 153(2), 169–179. PubMedCrossRef Silber, J. H., Gleeson, S. P., & Zhao, H. (1999). The influence of chronic disease on resource utilization in common acute pediatric conditions. Financial concerns for children’s hospitals. Archives of Pediatrics and Adolescent Medicine, 153(2), 169–179. PubMedCrossRef
go back to reference Vitiello, B. (2001). Psychopharmacology for young children: Clinical needs and research opportunities. Pediatrics, 108(4), 983–989. PubMedCrossRef Vitiello, B. (2001). Psychopharmacology for young children: Clinical needs and research opportunities. Pediatrics, 108(4), 983–989. PubMedCrossRef
go back to reference Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. JAMA, the Journal of the American Medical Association, 283(8), 1025–1030. CrossRef Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. JAMA, the Journal of the American Medical Association, 283(8), 1025–1030. CrossRef
go back to reference Zito, J. M., Safer, D. J., Valluri, S., Gardner, J. F., Korelitz, J. J., & Mattison, D. R. (2007). Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. Journal of Child and Adolescent Psychopharmacology, 17(2), 195–203. PubMedCrossRef Zito, J. M., Safer, D. J., Valluri, S., Gardner, J. F., Korelitz, J. J., & Mattison, D. R. (2007). Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. Journal of Child and Adolescent Psychopharmacology, 17(2), 195–203. PubMedCrossRef
go back to reference Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. (2005). Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services, 56(2), 157–163. PubMedCrossRef Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. (2005). Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services, 56(2), 157–163. PubMedCrossRef
go back to reference Zuckerman, M. L., Vaughan, B. L., Whitney, J., Dodds, A., Yakhkind, A., MacMillan, C., et al. (2007). Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: A retrospective chart review. Journal of Child and Adolescent Psychopharmacology, 17(2), 165–174. PubMedCrossRef Zuckerman, M. L., Vaughan, B. L., Whitney, J., Dodds, A., Yakhkind, A., MacMillan, C., et al. (2007). Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: A retrospective chart review. Journal of Child and Adolescent Psychopharmacology, 17(2), 165–174. PubMedCrossRef
go back to reference Zuvekas, S. H., & Vitiello, B. (2012). Stimulant medication use in children: A 12-year perspective. American Journal of Psychiatry, 169(2), 160–166. PubMedCentralPubMedCrossRef Zuvekas, S. H., & Vitiello, B. (2012). Stimulant medication use in children: A 12-year perspective. American Journal of Psychiatry, 169(2), 160–166. PubMedCentralPubMedCrossRef
go back to reference Zuvekas, S. H., Vitiello, B., & Norquist, G. S. (2006). Recent trends in stimulant medication use among U.S. children. American Journal of Psychiatry, 163(4), 579–585. PubMedCrossRef Zuvekas, S. H., Vitiello, B., & Norquist, G. S. (2006). Recent trends in stimulant medication use among U.S. children. American Journal of Psychiatry, 163(4), 579–585. PubMedCrossRef
Metagegevens
Titel
Trends in Psychotropic Medication Use for Medicaid-Enrolled Preschool Children
Auteurs
Cynthia A. Fontanella
Danielle L. Hiance
Gary S. Phillips
Jeffrey A. Bridge
John V. Campo
Publicatiedatum
01-05-2014
Uitgeverij
Springer US
Gepubliceerd in
Journal of Child and Family Studies / Uitgave 4/2014
Print ISSN: 1062-1024
Elektronisch ISSN: 1573-2843
DOI
https://doi.org/10.1007/s10826-013-9761-y

Andere artikelen Uitgave 4/2014

Journal of Child and Family Studies 4/2014 Naar de uitgave